China SXT Pharmaceuticals, Inc. (SXTC)
CIK 1723980 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for China SXT Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 28, 2026 | 6-K | 0001213900-26-095147 |
| Aug 28, 2026 | F-3/A | 0001213900-26-095149 |
| Jul 24, 2026 | 424B5 | 0001213900-26-081135 |
| Jul 24, 2026 | 6-K | 0001213900-26-081405 |
| Jul 7, 2026 | F-3 | 0001213900-26-075977 |
| Jul 6, 2026 | 6-K | 0001213900-26-075528 |
| Jul 1, 2026 | 20-F | 0001213900-26-074310 |
| Jun 1, 2026 | 6-K | 0001213900-26-063591 |
| Jun 1, 2026 | 424B5 | 0001213900-26-063590 |
| May 4, 2026 | 6-K | 0001213900-26-051679 |
| Apr 27, 2026 | 3 | 0001213900-26-048006 |
| Apr 27, 2026 | 3 | 0001213900-26-048000 |
| Apr 27, 2026 | 3 | 0001213900-26-048003 |
| Apr 27, 2026 | 3 | 0001213900-26-048001 |
| Apr 27, 2026 | 3 | 0001213900-26-048005 |
| Apr 27, 2026 | 3 | 0001213900-26-048007 |
| Apr 27, 2026 | 3 | 0001213900-26-047998 |
| Apr 9, 2026 | 424B5 | 0001213900-26-041766 |
| Apr 9, 2026 | 6-K | 0001213900-26-041765 |
| Jan 13, 2026 | 6-K | 0001213900-26-003910 |
| Jan 12, 2026 | 424B5 | 0001213900-26-003205 |
| Dec 31, 2025 | 6-K | 0001213900-25-127097 |
| Nov 14, 2025 | EFFECT | 9999999995-25-003288 |
| Aug 7, 2025 | SCHEDULE 13G | 0001213900-25-072835 |
| Aug 7, 2025 | SCHEDULE 13G | 0001213900-25-072832 |